Cannabis Extract Market
By Active Ingredient;
Tetrahydrocannabinol, Cannabidiol, Cannabigerol and CannabinolBy Product;
Oils and TincturesBy Type;
Full Spectrum Extracts and Cannabis IsolatesBy Indication;
Muscle Disorder, Neurological Disorder, Pain Management and Recreation UseBy Distribution Channel;
Hospital Pharmacies, Retail Pharmacies and Online PharmaciesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Cannabis Extract Market Overview
Cannabis Extract Market (USD Million)
Cannabis Extract Market was valued at USD 13,142.00 million in the year 2024. The size of this market is expected to increase to USD 42,614.24 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.3%.
Cannabis Extract Market
*Market size in USD million
CAGR 18.3 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 18.3 % |
Market Size (2024) | USD 13,142.00 Million |
Market Size (2031) | USD 42,614.24 Million |
Market Concentration | Low |
Report Pages | 386 |
Major Players
- Canopy Growth Corporation.
- Aphria, Inc
- Aurora Cannabis
- Maricann Group, Inc.
- Tilray.
- GW Pharmaceuticals, plc.
- ABcann Medicinals, Inc.
- Organigram Holding, Inc.
- Gibraltar Industry
- Green Mill Supercritical
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Cannabis Extract Market
Fragmented - Highly competitive market without dominant players
The Cannabis Extract Market is growing through major technological advancements, with more than 60% of innovation in premium extraction techniques like supercritical CO₂ and ethanol distillation. These methods enhance efficacy, ensuring consistent cannabinoid content and cleaner profiles. That fidelity is fueling reliable growth and strengthening end‑user trust.
Industry Partnerships Raising Product Integrity
Nearly 50% of extract improvements stem from collaboration and partnerships across extraction specialists, agritech innovators, and clinical research labs. These strategies standardize terpene retention, reinforce testing frameworks, and verify safety compliance. Such alliances are enabling broader expansion into therapeutic and lifestyle applications.
Innovative Formats Advancing Consumer Experience
Over 55% of product innovation emphasizes innovation in formulations—such as nano‑emulsified tinctures, vape-ready cartridges, and skin patches. These advancements improve bioavailability, speed of effect, and dosing comfort. Format-centric progress is supporting the market’s future outlook and driving steady growth.
Digital Quality Platforms Supporting Consumer Safety
With over 50% of operators deploying AI‑powered analytics and immutable tracking systems, product consistency and safety monitoring have significantly improved. These platforms log cannabinoid profiles, detect contaminants, and maintain compliance records. Integrating tech oversight with extraction workflows highlights essential technological advancements, fueling sustained growth and a robust future outlook.
Cannabis Extract Market Recent Developments
-
In January 2022, Gibraltar Industry introduced the Delta Ethanol Extraction CUP-5, a new closed-loop cold alcohol extraction technology designed specifically for cannabis processing. This advanced technology represents a significant leap in extraction methods, offering enhanced efficiency and precision in cannabinoid extraction.
-
In October 2021, Green Mill Supercritical launched the PARALLEL PRO equipment for cannabis extraction. This product features a competitive design that simplifies and lowers costs associated with scaling up production capacity by expanding extraction components.
Cannabis Extract Market Segment Analysis
In this report, the Cannabis Extract Market has been segmented by Active Ingredient, Product, Type, Indication, Distribution Channel and Geography.
Cannabis Extract Market, By Active Ingredient
The Cannabis Extract Market has been segmented by Active Ingredient into Tetrahydrocannabinol, Cannabidiol, Cannabigerol and Cannabinol.
Tetrahydrocannabinol
Tetrahydrocannabinol or THC holds the largest share in the cannabis extract market, contributing around 45%. Its psychoactive properties and increasing use in medical cannabis formulations for pain relief, nausea and appetite stimulation are driving demand. Regulatory shifts toward legalization are also fueling market growth.
Cannabidiol
Cannabidiol or CBD accounts for nearly 35% of the market. Known for its non-psychoactive effects, it is widely used in wellness, skincare and therapeutic products. Growing consumer preference for natural remedies and expanding acceptance of CBD-based health products are major growth drivers.
Cannabigerol
Cannabigerol or CBG represents about 12% of the total market. It is gaining attention for its potential anti-inflammatory and neuroprotective properties. Increasing investment in CBG research and product development is supporting its emerging commercial adoption.
Cannabinol
Cannabinol or CBN contributes close to 8% of the market. It is primarily used for its reported sedative effects and is being incorporated into sleep aids and relaxation-focused formulations. Niche applications and rising awareness are expected to boost its market presence.
Cannabis Extract Market, By Product
The Cannabis Extract Market has been segmented by Product into Oils and Tinctures.
Oils
Oils dominate the cannabis extract market, accounting for approximately 70% of the total share. Their popularity stems from high potency, ease of use and wide applications in both medical and recreational products. The demand for CBD oils in wellness and pain management continues to surge globally.
Tinctures
Tinctures hold around 30% of the market and are favored for their rapid absorption and ease of dosing. They are commonly used for anxiety relief, sleep support and general wellness. Growing interest in sublingual delivery is expected to drive the expansion of tincture-based products.
Cannabis Extract Market, By Type
The Cannabis Extract Market has been segmented by Type into Full Spectrum Extracts and Cannabis Isolates.
Full Spectrum Extracts
Full spectrum extracts dominate the cannabis extract market, holding nearly 65% of the total share. These extracts contain a wide range of cannabinoids, terpenes and other plant compounds, offering enhanced therapeutic benefits through the entourage effect. Consumers seeking holistic relief increasingly prefer full spectrum products.
Cannabis Isolates
Cannabis isolates account for approximately 35% of the market. These extracts contain a single, purified cannabinoid, such as CBD isolate or THC isolate. They are ideal for users needing precise dosing or avoiding specific compounds and are widely used in pharmaceutical formulations and cosmetic products.
Cannabis Extract Market, By Indication
The Cannabis Extract Market has been segmented by Indication into Muscle Disorder, Neurological Disorder, Pain Management and Recreation use.
Muscle Disorder
Muscle disorder applications account for around 20% of the cannabis extract market. These extracts are increasingly used for managing muscle spasms, inflammation and related conditions such as multiple sclerosis. Growing clinical evidence supports the effectiveness of cannabinoids in neuromuscular symptom relief.
Neurological Disorder
Neurological disorder treatment holds approximately 25% of the market. Cannabis extracts are being explored for conditions like epilepsy, Parkinson’s and Alzheimer’s, due to their potential neuroprotective properties. Regulatory approvals for CBD-based treatments are accelerating growth in this segment.
Pain Management
Pain management dominates the indication segment with nearly 35% market share. Cannabis extracts are widely used to address chronic pain, arthritis and neuropathic conditions. High demand for non-opioid alternatives is driving adoption across both medical and wellness markets.
Recreation Use
Recreation use contributes close to 20% of the overall market. The growing legalization of cannabis for adult use, especially in North America, has led to increased demand for THC-rich extracts offering relaxation, euphoria and stress relief effects.
Cannabis Extract Market, By Distribution Channel
The Cannabis Extract Market has been segmented by Distribution Channel into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.
Hospital Pharmacies
Hospital pharmacies hold approximately 30% of the cannabis extract market. These channels are crucial for the distribution of prescription-based formulations used in clinical treatments. They ensure higher regulatory compliance and offer patients access to expert medical supervision.
Retail Pharmacies
Retail pharmacies account for nearly 45% of the market, making them the leading distribution channel. They offer easy access to CBD wellness products, topicals and OTC cannabis-based remedies. Their wide reach helps boost consumer awareness and product availability.
Online Pharmacies
Online pharmacies contribute about 25% of the market. This channel is rapidly growing due to increasing preference for home delivery, discreet purchasing and access to a wider range of cannabis extracts. Digital platforms also support better consumer education.
Cannabis Extract Market, By Geography
In this report, the Cannabis Extract Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa & Latin America.
Regions and Countries Analyzed in this Report
Cannabis Extract Market Share (%), by Geographical Region
North America
North America leads the cannabis extract market, accounting for nearly 50% of the total share. This dominance is driven by early legalization efforts, established distribution networks and strong presence of cannabis manufacturers in the US and Canada.
Europe
Europe holds around 20% of the market. Increasing acceptance of medical cannabis, supportive regulatory frameworks and rising demand for CBD products in countries such as Germany, the UK and the Netherlands are boosting regional growth.
Asia Pacific
Asia Pacific represents approximately 15% of the global market. Emerging legal reforms in countries like Thailand and Australia, combined with growing investment in cannabis research and export infrastructure, are fueling rapid expansion in the region.
Middle East & Africa
Middle East and Africa contribute about 8% of the market. While regulatory challenges remain, countries like South Africa and Israel are making strides with medical cannabis programs, supported by investments in cultivation and clinical trials.
Latin America
Latin America accounts for nearly 7% of the global share. Markets in Brazil, Uruguay and Colombia are emerging as hubs for low-cost cultivation, export-oriented production and cannabinoid innovation.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Cannabis Extract Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Advances in extraction technologies
- Shifting attitudes towards cannabis use
- Cannabis entering mainstream healthcare
-
Technological improvements in extraction methods - Technological advancements in cannabis extraction methods have significantly transformed the industry, enhancing efficiency, quality, and scalability of cannabinoid production. Traditional methods, such as solvent extraction and distillation, have evolved with innovations like closed-loop systems and supercritical CO2 extraction. These technologies allow for precise control over temperature, pressure, and solvent ratios, ensuring optimal extraction of cannabinoids while minimizing impurities.
Advancements in extraction equipment design and automation have streamlined processes, reducing production costs and increasing throughput. The adoption of these advanced extraction methods not only improves product consistency and purity but also supports the development of novel cannabis-derived formulations tailored to meet specific consumer needs and regulatory standards.
Restraints:
- Quality control issues in manufacturing
- Supply chain and logistical hurdles
-
Concerns over product safety - Product safety remains a critical concern in the cannabis industry, driven by regulatory requirements and consumer expectations for quality assurance. The complexity of cannabis products, including varying cannabinoid profiles and potential contaminants, poses challenges for ensuring consistent safety standards. Key issues include pesticide residues, heavy metals, microbial contaminants, and solvent residues from extraction processes.
Regulatory frameworks in legalized markets often mandate rigorous testing protocols to mitigate these risks and safeguard consumer health. Industry efforts focus on implementing comprehensive quality control measures throughout the cultivation, extraction, and manufacturing stages. Advances in analytical testing technologies enable accurate detection and quantification of contaminants, supporting compliance with safety regulations and enhancing consumer confidence in cannabis products.
Opportunities:
- Advances in extraction technologies
- Blockchain for supply chain transparency
- Cannabis-based nutraceuticals
-
Research in genetics and breeding - Research in cannabis genetics and breeding plays a pivotal role in advancing the development of high-quality and specialized cannabis strains tailored for specific therapeutic and consumer preferences. Genetic studies aim to identify and manipulate genes responsible for cannabinoid production, terpene profiles, and plant morphology. This research facilitates the breeding of cultivars with optimized traits such as higher cannabinoid content, enhanced flavor profiles, and improved resistance to pests and diseases.
Genetic research supports the development of stable and reproducible seed lines, ensuring consistency in cannabinoid composition and product performance across cultivation cycles. Collaborations between academia, biotechnology firms, and cannabis cultivators drive innovation in genetics, paving the way for sustainable and efficient cannabis cultivation practices while meeting evolving market demands.
Competitive Landscape Analysis
Key players in Global Cannabis Extract Market include:
- Canopy Growth Corporation.
- Aphria, Inc
- Aurora Cannabis
- Maricann Group, Inc.
- Tilray.
- GW Pharmaceuticals, plc.
- ABcann Medicinals, Inc.
- Organigram Holding, Inc.
- Gibraltar Industry
- Green Mill Supercritical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Active Ingredient
- Market Snapshot, By Product
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channe
- Market Snapshot, By Region
- Cannabis Extract Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advances in extraction technologies
- Shifting attitudes towards cannabis use
- Cannabis entering mainstream healthcare
- Technological improvements in extraction methods
- Restraints
- Quality control issues in manufacturing
- Supply chain and logistical hurdles
- Concerns over product safety
- Opportunities
- Advances in extraction technologies
- Blockchain for supply chain transparency
- Cannabis-based nutraceuticals
- Research in genetics and breeding
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
-
Cannabis Extract Market, By Product, 2021 - 2031 (USD Million)
-
Tetrahydrocannabinol
-
Cannabidiol
-
Cannabigerol
-
Cannabinol
-
- Cannabis Extract Market, By Product, 2021 - 2031 (USD Million)
- Oils
- Tinctures
- Cannabis Extract Market, By Type, 2021 - 2031 (USD Million)
- Full Spectrum Extracts
- Cannabis Isolates
- Cannabis Extract Market, By Indication, 2021 - 2031 (USD Million)
- Muscle Disorder
- Neurological Disorder
- Pain Management
- Recreation Use
- Cannabis Extract Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Cannabis Extract Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
-
- Competitive Landscape Analysis
- Company Profiles
- Canopy Growth Corporation.
- Aphria, Inc
- Aurora Cannabis
- Maricann Group, Inc.
- Tilray.
- GW Pharmaceuticals, plc.
- ABcann Medicinals, Inc.
- Organigram Holding, Inc.
- Gibraltar Industry
- Green Mill Supercritical
- Company Profiles
- Analyst Views
- Future Outlook of the Market